Advertisement
Advertisement

BIAF

BIAF logo

bioAffinity Technologies, Inc. Common Stock

1.18
USD
Sponsored
-0.08
-6.35%
Jan 29, 15:56 UTC -5
Closed
exchange

After-Market

1.17

-0.01
-0.85%

BIAF Earnings Reports

Positive Surprise Ratio

BIAF beat 1 of 6 last estimates.

17%

Next Report

Date of Next Report
Mar 30, 2026
Estimate for Q4 25 (Revenue/ EPS)
$1.58M
/
-$2.75
Implied change from Q3 25 (Revenue/ EPS)
+9.55%
/
-41.98%
Implied change from Q4 24 (Revenue/ EPS)
-28.26%
/
-56.35%

bioAffinity Technologies, Inc. Common Stock earnings per share and revenue

On Nov 14, 2025, BIAF reported earnings of -4.74 USD per share (EPS) for Q3 25, missing the estimate of -2.75 USD, resulting in a -72.11% surprise. Revenue reached 1.45 million, compared to an expected 1.44 million, with a 0.47% difference. The market reacted with a -2.13% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 3 analysts forecast an EPS of -2.75 USD, with revenue projected to reach 1.58 million USD, implying an decrease of -41.98% EPS, and increase of 9.55% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Nurix Therapeutics, Inc. Common stock
Report Date
Jan 28, 2026 For Q4 25
Estimate
-$0.88
Actual
-$0.82
Surprise
+7.66%
FAQ
For Q3 2025, bioAffinity Technologies, Inc. Common Stock reported EPS of -$4.74, missing estimates by -72.11%, and revenue of $1.45M, 0.47% above expectations.
The stock price moved down -2.13%, changed from $1.88 before the earnings release to $1.84 the day after.
The next earning report is scheduled for Mar 30, 2026.
Based on 3 analysts, bioAffinity Technologies, Inc. Common Stock is expected to report EPS of -$2.75 and revenue of $1.58M for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement